×
About 995 results

ALLMedicine™ Chronic Gastritis Center

Research & Reviews  366 results

Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios ...
https://doi.org/10.1177/17246008211072875
The International Journal of Biological Markers; Zhang L, Qin S et. al.

Jan 12th, 2022 - This study aimed to investigate the diagnostic value of prealbumin-to-fibrinogen ratio (PFR) and albumin-to-fibrinogen ratio (AFR) alone or in combination in Helicobacter pylori-negative gastric cancer (Hp-NGC) patients. This study included 171 he...

Machine learning-based personalised prediction of gastric cancer incidence using the en...
https://doi.org/10.1016/j.gie.2021.12.033
Gastrointestinal Endoscopy; Arai J, Aoki T et. al.

Jan 10th, 2022 - Accurate risk stratification for gastric cancer is required for optimal endoscopic surveillance in patients with chronic gastritis. We aimed to develop a machine learning (ML) model that incorporates endoscopic and histological findings for an ind...

Helicobacter species binding to the human gastric mucosa.
https://doi.org/10.1111/hel.12867
Helicobacter Matos R, Sousa HS et. al.

Dec 31st, 2021 - Helicobacter pylori infects half of the world population, being associated with several gastric disorders, such as chronic gastritis and gastric carcinoma. The Helicobacter genus also includes other gastric helicobacters, such as H. heilmannii¸ H....

Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in...
https://doi.org/10.1111/dom.14632
Diabetes, Obesity & Metabolism; Meier JJ, Granhall C et. al.

Dec 28th, 2021 - To investigate whether upper gastrointestinal (GI) disease has any effect on the exposure of oral semaglutide, an important consideration given that its absorption occurs primarily in the stomach. In an open-label, parallel-group trial (NCT0287735...

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolido...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701960
Medicine Wang J, Cao Y et. al.

Dec 24th, 2021 - Helicobacter pylori (H pylori) infection can cause chronic gastritis, peptic ulcer, and even gastric cancer, so effective eradication is critical.This study compared the efficacy and safety of bismuth quadruple regimens including either tetracycli...

see more →

Guidelines  1 results

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  14 results

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
https://clinicaltrials.gov/ct2/show/NCT04341454

Dec 21st, 2021 - This study was designed as a multi-center, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study to assess the efficacy and safety of oral administration of DWP14012 X mg QD, Y mg BID and placebo for 2 weeks in patients with ...

European Registry on the Management of Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT02328131

Aug 31st, 2021 - Abstract Introduction: H. pylori selectively infects the human stomach mucosa, being the most prevalent chronic infection in the world. Its prevalence correlates with socioeconomic factors and it is higher in older individuals. H. pylori presence ...

Metabonomics Study of Chronic Gastritis and Gastric Carcinoma
https://clinicaltrials.gov/ct2/show/NCT04624282

Jan 20th, 2021 - This project was an untargeted metabolomics study using liquid chromatography coupled with mass spectrometry (LC-MS) in patients with chronic gastritis and gastric carcinoma. The experimental procedures mainly include sample collection, metabolite...

A Study to Evaluate the Efficacy and Safety of AD-203
https://clinicaltrials.gov/ct2/show/NCT04066530

Dec 2nd, 2020 - This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or ...

Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC
https://clinicaltrials.gov/ct2/show/NCT04638959

Nov 20th, 2020 - We conducted a large-scale multi-centre retrospective case-control study. Approximately a total of 1080 volunteers aging 40-75 in three independent cohorts, discovery cohort, validation cohort 1, validation cohort 2, will be recruited from 10 hosp...

see more →

News  15 results

Fast Five Quiz: Helicobacter pylori
https://reference.medscape.com/viewarticle/950663

May 17th, 2021 - Helicobacter pylori is a gram-negative microaerophilic bacterium that infects the epithelial lining of the stomach. It is the chief cause of chronic gastritis and the primary etiological agent for gastric cancer and peptic ulcer disease (PUD). Des...

Pink plaque on the ear
https://www.mdedge.com/familymedicine/article/237252/dermatology/pink-plaque-ear
MDedge Family Medicine;

Mar 25th, 2021 - A 4-mm punch biopsy was performed and revealed B-cell lymphoma, consistent with extranodal marginal zone lymphoma. The plaque was palpated carefully and the location of branches of the superficial temporal artery, which usually course anterior to.

Chronic Gastritis, a Lesion, and Weight Loss in a Teenager
https://reference.medscape.com/viewarticle/843821

Feb 19th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Expert Highlights Assay to Determine Patients With Lung, Gastrointestinal Cancers to Receive Pembrolizumab
https://www.onclive.com/view/expert-highlights-assay-to-determine-patients-with-lung--gastrointestinal-cancers-to-receive-pembrolizumab-

Dec 4th, 2020 - Lawrence M. Weiss, MD The PD-L1 immunohistochemistry (IHC) 22C3 pharmDx can be an aid in identifying patients with non—small cell lung cancer (NSCLC) and gastrointestinal cancers who are eligible for pembrolizumab (Keytruda) monotherapy, accordin...

What is your diagnosis? - March 2020
https://www.mdedge.com/gihepnews/article/218065/what-your-diagnosis-march-2020
Diogo Turiani Hourneaux de Moura, MD, MSc, PhD, Kelly E. Hathorn et. al.

Feb 28th, 2020 - Squamous metaplasia Weight regain can accompany re-emergence of obesity-related comorbidities and, thus, early intervention is important. Although diet, exercise, and behavior modifications are fundamental, they can have limited efficacy.

see more →

Patient Education  1 results see all →